Mariner, LLC Astrazeneca PLC Transaction History

Mariner, LLC

$75.9 Billion
Q3 2025

A detailed history of Mariner, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mariner, LLC holds 672,519 shares of AZN stock, worth $60.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

672,519

Previous 662,081 1.58%

Holding current value

$60.1 Million

Previous $46.3 Million 11.52%

% of portfolio

0.07%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $717,299 - $857,064	10,438 Added 1.58%	672,519 $51.6 Million
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $13.4 Million - $15.5 Million	206,494 Added 45.32%	662,081 $46.3 Million
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $16.3 Million - $19.5 Million	250,017 Added 121.62%	455,587 $33.5 Million
Q4 2024 Feb 13, 2025	BUY	$63.2 - $79.58 $1.64 Million - $2.07 Million	25,998 Added 14.48%	205,570 $13.5 Million
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $448,826 - $512,927	5,854 Added 3.37%	179,572 $14 Million

Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $3.91 Million - $4.73 Million	58,475 Added 50.74%	173,718 $13.5 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $1.65 Million - $1.89 Million	-27,115 Reduced 19.05%	115,243 $7.81 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $177,686 - $198,902	-2,871 Reduced 1.98%	142,358 $9.59 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $367,569 - $406,395	-5,668 Reduced 3.76%	145,229 $9.83 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $278,661 - $302,178	3,986 Added 2.71%	150,897 $10.8 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $2.14 Million - $2.43 Million	33,926 Added 30.03%	146,911 $10.2 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $304,605 - $395,802	-5,619 Reduced 4.74%	112,985 $7.66 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $3.1 Million - $7.94 Million	58,459 Added 97.2%	118,604 $6.5 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $147,379 - $176,925	-2,487 Reduced 3.97%	60,145 $3.97 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $264,001 - $318,014	4,738 Added 8.18%	62,632 $4.16 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $623,228 - $736,406	11,537 Added 24.89%	57,894 $3.37 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $569,767 - $623,401	10,255 Added 28.41%	46,357 $2.78 Million
Q2 2021 Aug 24, 2021	BUY	$48.42 - $60.18 $95,048 - $118,133	1,963 Added 5.75%	36,102 $2.16 Million
Q1 2021 May 07, 2021	BUY	$47.16 - $54.44 $234,668 - $270,893	4,976 Added 17.06%	34,139 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $359,630 - $430,044	-7,412 Reduced 20.27%	29,163 $1.46 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $135,806 - $156,354	-2,559 Reduced 6.54%	36,575 $2.01 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $444,102 - $569,914	10,304 Added 35.74%	39,134 $2.07 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $432,015 - $586,804	11,432 Added 65.71%	28,830 $1.29 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $15,030 - $17,862	354 Added 2.08%	17,398 $867,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $27,281 - $30,919	-680 Reduced 3.84%	17,044 $760,000
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $108,559 - $121,372	2,912 Added 19.66%	17,724 $732,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $525,677 - $637,212	14,812 New	14,812 $599,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $246,656 - $281,853	-7,096 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $245,166 - $262,906	7,096 New	7,096 $249,000

Others Institutions Holding AZN

# of Institutions

1,497

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account